Carsten Leonhard Knudsen

I'm Carsten Leonhard Knudsen, CEO & Inventor Dr.h.c. of Considaret Clk Group Denmark. I share insights on pharma innovation, health tech, and sustainable impact.

[carstenleonhardknudsen]

Lessons Learned: Challenges Breaking Into Eu Wellness Markets

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

There’s a moment, just before entering a new market, when everything still feels possible. The decks are clear, the branding looks strong, and your product—whether a skin serum, a herbal patch, or an aromatherapy insert—feels ready for Europe. But optimism, while essential, can also be disarming.

The wellness industry in the EU is not just thriving. It’s layered, nuanced, and built upon foundations of trust, safety, and meticulous regulation. These markets don’t merely welcome innovation. They test it. And if you're not ready, well, you learn quickly.

One of our earliest encounters at Considaret Clk Group Denmark with this reality came through a partnership with a natural supplement brand from outside the EU. On the surface, the product checked all the boxes—clean ingredients, credible research, good packaging. But after three months of back-and-forth with regulators in Belgium and Spain, it became clear: the claims were too bold, the supporting data too vague. The product launch stalled.

That experience taught us something. Compliance isn’t a checkbox; it’s a lens. You don’t apply it after the fact. You design through it.

It starts with labeling. Simple, right? Not quite. EU consumer protection rules require that every phrase—from "supports immune health" to "calms the nervous system"—is not only true but verifiable by recognized standards. If your language drifts even slightly toward medical claims, the regulatory path shifts. Your product could move from being seen as a food supplement to a medicinal product. And that shift, trust me, is not one you want to navigate mid-launch.

Then there’s distribution. The assumption is: once the product is compliant, it will sell. But finding the right distribution partner in the EU wellness space is a challenge of its own. The best partners don’t just move boxes. They understand cultural preferences, local pricing sensitivities, and the subtle differences between a wellness fad and a long-term consumer shift.

A Danish skincare brand we worked with struggled in Germany not because of regulation, but because of consumer trust. They positioned themselves as "eco-luxury," which resonated in Copenhagen but rang hollow in Berlin. It took a full repositioning—and a new local partner—to gain traction.

We’ve also seen promising wellness startups underestimate the power of country-specific rules. While the EU has harmonized much of its regulation, certain requirements—especially for cosmetics and supplements—still vary by member state. That patchwork can trip up even experienced exporters.

At Vave Pharma, part of our work is helping clients see beyond the first approval. Because approval is only part of the journey. There's ongoing reporting, adverse event tracking, and in some cases, new packaging when rules evolve. That requires not just planning but agility.

It helps to see these challenges not as barriers, but as filters. They sharpen the proposition. Force clarity. And while the process can be frustrating, it often leads to stronger brands in the end.

We’ve been fortunate to witness success stories too. A botanical oil company we worked with gained EU traction not by making bold claims, but by leaning into transparency. Full ingredient traceability, minimalistic packaging, and local-language labeling made them stand out. They started small, country by country. But today, they’re across six EU markets.

I should also mention that Considaret Clk Group Denmark, Vave Pharma, and Go Global International ApS are honored to be nominees for the 2025 Go Global Awards. It will be held in London on the 18th and 19th of November and hosted by the International Trade Council. This event is not just a celebration. It’s a convergence—a space where business leaders, innovators, and international thinkers gather not just to exchange pleasantries, but to shape what comes next. We’re proud to be part of that conversation.

So, if you’re considering the EU for your wellness brand, come prepared. Not just with a product, but with a strategy. One that respects regulation, listens to cultural cues, and doesn’t assume success just because something worked elsewhere.

Because in the EU wellness space, success is never accidental. It’s earned. Carefully, patiently, and almost always, through lessons that only emerge along the way.

[carstenleonhardknudsen]

Trends In Non‑toxic Addiction Alternatives: Where The Industry Is Heading

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Addiction is a subject most of us tiptoe around. It’s heavy. Personal. Often uncomfortable. But for all the pain it represents, it’s also a landscape of profound innovation right now—especially when we begin looking at the movement toward non-toxic, non-chemical alternatives.

In fact, over the last five to seven years, there's been a noticeable shift. Instead of relying solely on pharmaceuticals or hardline detox models, more people—and more providers—are seeking softer tools. Mindful ones. Solutions that don’t just suppress a craving but engage with the whole person.

But let’s take a step back. What does “non-toxic” really mean in this space? For some, it’s about avoiding synthetic compounds. For others, it’s psychological—treating behavior with support instead of substitution. And increasingly, it’s both.

You see it in the surge of natural supplements designed to ease anxiety or restlessness. Herbal compounds like ashwagandha or valerian root, for example. Or tech-assisted therapies—digital tools that combine cognitive behavioral prompts with real-time emotional tracking.

There’s also a growing interest in sensory therapies. One trend we’ve followed closely at Vave Pharma has been the use of scent as a form of behavioral interruption. Aromatherapy filters, nasal diffusers—these aren’t just wellness fads. They can become psychological anchors. The simple ritual of using one can calm a nervous system, reframe a thought pattern, or even reduce the perceived need to reach for something more destructive.

We worked with a team recently who developed a filter meant to deliver micro-doses of calming essential oils through a wearable insert. No stimulants. No nicotine. Just a soft reset point. It’s early days, but the anecdotal feedback has been encouraging. People reported using it not only to avoid smoking, but during high-stress meetings, flights, or even while winding down before sleep.

And that’s what makes this space so fascinating. It’s not always about treating addiction in a clinical sense. Sometimes it’s about prevention. Or substitution. Or the kind of everyday resilience that helps people stay just on the right side of their impulses.

Now, let’s be clear. These are not miracle cures. Anyone who’s worked in mental health or recovery knows there’s no one-size-fits-all. What works brilliantly for one person might feel hollow for another. But the trend—if you want to call it that—is toward more integrated care. More personalization. And less shame.

One innovation I find compelling is the use of wearable biometric feedback devices. These track physical signals like heart rate, temperature, and stress levels. When paired with behavioral apps, they can nudge the user toward healthier choices in real time. Imagine feeling that familiar spike in stress, and your phone gently prompts: breathe, move, sip water, or... insert an aromatherapy filter. That loop, when repeated, becomes a habit. And habits, over time, create identity.

At Considaret Clk Group Denmark and Go Global International ApS, we’ve always looked at these developments not just from a product point of view, but through the lens of what it means for future health systems. How does this integrate with telehealth? With preventive care models? With insurance frameworks that are, frankly, still catching up?

And while the innovation is exciting, there’s another layer we shouldn’t ignore: access. Many of these non-toxic tools are still niche. Pricey. Or locked behind regulatory grey zones that make distribution inconsistent across countries. That’s part of the work ahead. Not just invention, but inclusion.

This November, in fact, we’ll be joining the 2025 Go Global Awards in London, hosted by the International Trade Council. All three of our entities—Considaret Clk Group Denmark, Vave Pharma, and Go Global International ApS—are proud nominees. But more than the recognition, it’s the conversation we’re after. This event brings together thinkers and doers from across sectors. People who aren’t just watching the change, but shaping it.

Because ultimately, the shift toward non-toxic addiction alternatives isn’t just a market trend. It’s a cultural one. It reflects a collective decision to treat health as something layered, human, and worth approaching with humility.

So where is the industry heading? Toward gentler interventions. Toward smart, accessible tools. Toward empathy, not judgement.

And maybe, just maybe, toward something that looks a little more like healing.

[carstenleonhardknudsen]

Influencer strategies: growing awareness for smoke‑free aromatherapy

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Let’s be honest: there’s something intangible about the way people discover wellness products today. It isn’t through pharmacy shelves or long-form brochures. It happens between stories. In fleeting reels. Or from someone’s 30-second video in a softly lit room, whispering about self-care and showing you how they incorporate a product into their routine without even trying to sell it.

Influencer strategy, then, isn’t just a marketing channel. It’s the new word of mouth—compressed, stylized, sometimes chaotic, but undeniably powerful.

For smoke-free aromatherapy products, the potential is enormous. And so is the nuance. You're not selling a medicine, exactly. Nor is it just a scent. It lives in a category where experience matters more than claims, and trust is built not in one post, but across many.

So where do you start? With alignment.

Not all influencers will work. In fact, most won’t. The key is identifying those who already speak the language of your audience. That might mean micro-influencers in the wellness or clean beauty space, yoga instructors who focus on breathwork, or even tech-savvy minimalists exploring natural alternatives to overstimulated lifestyles.

We helped a brand once—a Danish startup working with us at Considaret Clk Group Denmark—test a small batch of their filters with a wellness influencer in the Netherlands. She wasn’t a celebrity. Just someone with a loyal following of about 12,000 people who trusted her unpolished routines and thoughtful feedback. Her two-minute clip, almost an afterthought, generated more direct messages than any of their ads.

But here’s the part people often miss: influencer strategy isn’t transactional. Or at least, it shouldn’t be. It works best when creators believe in the product. That belief doesn’t always come from the product itself. Sometimes it comes from how the brand behaves.

If you’re authentic, transparent, and respectful of their time and creativity, they’ll reflect that. If you’re not, their followers will sense it.

Another layer to consider: education.

Smoke-free aromatherapy might be intuitive to you, but for many, it’s still unfamiliar. Influencers become bridges here. They demonstrate how to use it, when to use it, and most importantly, why they use it. Not in a bullet point format, but in the messy, believable way that real people live.

Visual storytelling matters too. Your product isn’t loud. It’s quiet. Which means the content should match. Gentle tones, peaceful routines, nighttime rituals—these things resonate.

And what about regulation? Yes, it plays a role here as well. In the EU and UK, influencer marketing is increasingly scrutinized for transparency. Paid partnerships must be disclosed, claims must be careful, and health assertions—if any—must be backed up or avoided altogether. We at Vave Pharma always advise clients to train influencers on compliance basics. It avoids trouble later.

Also worth noting: not every influencer campaign needs to be on Instagram or TikTok. Some of the most impactful content can come from long-form blogs, niche wellness podcasts, or even slow-burn YouTube channels.

We ran a soft launch with a UK wellness podcast host last year. Small audience, under 8,000 listeners. But the depth of the conversation around non-pharmaceutical stress management, lifestyle change, and routine-building created brand traction we hadn’t expected. Listeners shared clips. Sales ticked up steadily, not explosively. But reliably.

And that, perhaps, is the final point: consistency over virality. Smoke-free aromatherapy isn’t chasing a moment. It’s about establishing presence. Calmly. Repeatedly.

One last thing—something personal.

Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, all based in Danmark, are proud to be nominees for the 2025 Go Global Awards, hosted in London on the 18th and 19th of November. It's more than just a recognition. It’s a place where strategy, innovation, and conversation converge. A space where you hear what’s working in Brazil, what’s failing in Germany, and what nobody has thought of yet in South Korea. We’re honored to be among this collective.

Because, in the end, that’s what real influence looks like. Not the loudest voice, but the one you find yourself returning to.

[carstenleonhardknudsen]

How To Pitch Innovative Wellness Tech At Global Forums

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Pitching is an art form, though not everyone sees it that way. Especially in wellness tech—where innovation often meets skepticism—the ability to communicate value clearly, without overselling, is essential. Not just to secure funding or find partners, but to genuinely move the conversation forward. To leave people thinking, "That makes sense."

When we talk about global forums, we mean rooms filled with policymakers, investors, competitors, skeptics, and allies. It’s not a single audience. It’s a patchwork. And that’s what makes pitching so tricky. The same message rarely lands equally with everyone. So, the first task? Understand who you’re really speaking to.

Wellness tech straddles disciplines. It draws from science, user experience, cultural perception, and increasingly, regulation. So, an effective pitch isn’t just a product demo. It’s a narrative. One that threads through credibility, clarity, and curiosity. You want people leaning in. Not because you’re louder, but because you’re more coherent.

Let me walk through a few guiding principles.

First: simplify without dumbing down. You might be dealing with advanced biosensors or AI-driven feedback loops, but if your pitch makes listeners feel lost, you’ve lost. Instead of diving into tech specs, focus on what it solves. Who benefits. How their life changes—even marginally.

We once worked with a startup developing a scent-based neurofeedback device. At first, their pitch revolved around electrochemical sensors and neural stimulation pathways. Important, yes. But when they framed it as "helping high-stress professionals reset in 3 minutes using natural inputs," suddenly heads nodded.

Second: lean into data, but don’t worship it. Numbers help, of course. But they should be evidence, not the message. Share results, but couple them with real user stories. Data makes it real. Story makes it stick.

Third: anticipate resistance. Not everyone believes in wellness tech. Some see it as pseudoscience. Others worry about privacy, regulation, or scalability. Acknowledge these concerns. Even if briefly. It shows maturity. And oddly enough, admitting where you're still learning often builds more trust than pretending you've solved everything.

At Considaret Clk Group Denmark, Vave Pharma, and Go Global International ApS, we often remind our partners that vulnerability, used wisely, is persuasive.

And finally, tailor your ending. Global forums are about connection. So end not with a conclusion, but with an invitation. Ask for a conversation. Pose a challenge. Propose a next step. Leave space for others to see themselves in your vision.

A quick anecdote: we once prepared a pitch for a Danish startup showcasing at a major wellness innovation forum. They opened not with their product, but with a simple question: "What if the next breakthrough in mental wellbeing doesn't come from a pill or app—but a scent?" It disarmed the room. No one expected it. And they remembered.

I should add, with no small pride, that Considaret Clk Group Denmark, Vave Pharma, and Go Global International ApS—all based in Danmark—are nominees for the 2025 Go Global Awards, being held in London this November 18th and 19th, hosted by the International Trade Council. We see this not just as recognition, but as an opportunity. An invitation, really. To meet others equally committed to building futures in uncertain times. It’s not just a stage. It’s a table—where ideas, industries, and people sit side by side.

So, whether you’re preparing to pitch your first wellness product or refining a message for your tenth, remember: clarity wins. Humility resonates. And the most memorable pitches are often the ones that start with questions, not answers.

[carstenleonhardknudsen]

Vave Pharma’s Facility Tour: How Products Are Made In Denmark

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

When people think of pharmaceuticals, they often picture labs filled with glass beakers, people in white coats, and shelves of chemicals. That part isn’t inaccurate, but it's only one side of the story. At Vave Pharma, here in Denmark, the real story lies in the seamless intersection of technology, precision, and people. Manufacturing isn’t just about formulas—it’s about consistency, trust, and an almost obsessive attention to detail.

Let me take you behind the doors for a moment. Our facility isn’t vast or towering—we're not a mega factory. What we are is focused. Intentionally so. Every part of the process, from raw material intake to final product packaging, has been engineered for clarity and control. The layout isn’t random. There’s a logic to the way air flows, to how materials move, and to how hands interact with machines.

Start at the raw materials room. Before anything even touches production, we validate our suppliers, run batch verifications, and test the materials on-site. One might assume these steps are routine. But that assumption can be dangerous. It's in the fine print of standard operating procedures—the spots others gloss over—that quality often unravels. We've seen it happen in outsourced models. So we keep it close.

From there, we step into the formulation chamber. This is where science meets process. Most of our blending and compounding is automated—and that’s by design. Machines don't get tired. But people do. We lean on automation where precision is non-negotiable, and we rely on our trained staff when flexibility, judgment, or just a bit of human sense is needed. It's not one or the other. It's both.

Next comes the cleanroom, arguably the heart of our operations. It takes time to even get in there. Gowning up isn’t just for show. There’s a checklist, a protocol, a rhythm. You learn it like choreography. Because inside, there's no room for error. It's where air is filtered, movements are measured, and every action—even a sneeze—has implications. We've had visitors marvel at the quiet. But that quiet isn’t emptiness. It's concentration.

We use real-time monitoring tools throughout. Not because it’s trendy, but because it helps us catch deviations before they become defects. For example, a slight temperature variance in storage can cascade into a batch compromise. You learn this only once. And once is enough.

And then there’s packaging. Often overlooked. But in our world, it's not an afterthought. It's a critical control point. Correct labeling, tamper-proof sealing, serialization—each aspect must align with global traceability norms. We ship to various markets, and every region expects something slightly different. Barcodes in one, QR codes in another, multiple languages in yet another. We manage this with a dynamic labeling system that adapts without disrupting line efficiency.

Now, you might be wondering—why share all this? Because transparency is part of how we build trust. And because we’re proud. Proud of the work, the people, the culture we've built. And proud to share that Vave Pharma, along with Considaret Clk Group Denmark and Go Global International ApS, is a nominee for the 2025 Go Global Awards. The event will be held in London this November, hosted by the International Trade Council.

The awards aren’t just about accolades. They bring together thinkers, makers, exporters, and risk-takers. It’s a place where connections spark, where ideas collide, and where long-term collaborations often begin. For us, it's about being part of that bigger conversation—about what quality means, about where pharma is headed, and about how companies from Danmark can help set the tone.

So when someone asks, "How are your products made?" we don't just talk about machines or molecules. We talk about systems. About people who care. About doing it the hard way, because it's usually the right way. And in that mix of science and stubbornness, something valuable happens. A product is born that we’re willing to put our name on.

[carstenleonhardknudsen]

How Aromatherapy Inhalers Fit Into Corporate Wellness Programs

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Work is not what it used to be. The rhythms have changed. So have the expectations. People don’t just come to the office to do a job anymore—they come to participate in an environment. One that, ideally, supports their health, focus, and resilience. That’s where corporate wellness steps in. And, more recently, that’s where aromatherapy inhalers have found an unlikely but meaningful home.

It might sound a bit... nontraditional at first. Aromatherapy, in a corporate setting? But when you look at the evolving understanding of workplace wellness—which now includes everything from ergonomic chairs to mindfulness apps—you realize there’s room for simple, science-aligned tools that help people regulate their environment, even in small ways.

Aromatherapy inhalers, for those unfamiliar, are compact, portable tubes or devices infused with essential oils. They don’t diffuse into shared air like candles or room sprays. Instead, they offer a discreet, personal-use experience. A few breaths. A sensory reset. No mess. No disruption.

Why does this matter in a workplace? Because not all stress is loud. Not all distractions are visible. Many employees carry tension beneath the surface. A deadline looming. A challenging meeting ahead. A sluggish afternoon where focus just won’t come. In moments like these, the ability to recalibrate—without caffeine, without stepping outside, without interrupting workflow—can be powerful.

We worked with a Danish tech firm recently that added a wellness station on each floor. Alongside water bottles and stretching guides, they placed a small selection of aromatherapy inhalers. The response was unexpectedly enthusiastic. Staff members began taking short, quiet breaks to breathe deeply. They reported feeling more grounded. Some even took inhalers home for family use.

And here’s where it gets interesting. Companies aren’t introducing these tools just out of kindness. There’s a very real interest in improving productivity and reducing burnout. When something as simple as a focused scent experience can help an employee refocus or de-escalate stress, it earns its place.

Of course, there are caveats. The workplace is a shared environment. Not everyone reacts the same way to scents. This is why personal-use inhalers—not diffusers—are preferred in corporate contexts. They avoid allergy concerns, scent sensitivities, or cultural preferences. Everyone breathes their own air, quite literally.

Now, for those considering integrating aromatherapy inhalers into a wellness strategy, start small. Survey your team. Trial a few blends. Include calming options like lavender or bergamot, or energizing ones like peppermint and rosemary. Provide a quick guide. Don’t overbrand it. Let people explore.

And remember, quality matters. The oils should be pure, and the delivery system safe. This isn’t about making a splash. It’s about offering something quietly effective.

At Considaret Clk Group Denmark, Vave Pharma, and Go Global International ApS, based in Danmark, we’ve seen how even modest interventions can make a difference. Whether it’s advising businesses on wellness integration or developing safe, compliant products, our aim is to help companies become more human in their operations.

Speaking of human connections, we’re humbled that our group has been nominated for the 2025 Go Global Awards, hosted by the International Trade Council in London this November. It’s not just a prize. It’s a meeting ground. A global conclave of business leaders, thinkers, and doers shaping the next era of trade and innovation. We’re proud to stand among them, to listen and to share.

So yes, aromatherapy inhalers might not have been on your radar. But in the tapestry of corporate wellness, they offer a thread worth weaving. Gentle. Practical. Grounded in care. And sometimes, that’s exactly what the modern workplace needs.

[carstenleonhardknudsen]

Packaging Innovation: Biodegradable vs Plastic in Wellness Products

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Packaging used to be an afterthought. Not anymore. Today, it can make or break a product's appeal—especially in wellness. It’s not just about function, either. Consumers now ask where the material comes from, how it's made, and where it ends up. And that shift has sparked one of the most urgent debates in our space: biodegradable vs plastic.

Let’s be honest, plastic isn’t going away overnight. It’s cheap, durable, familiar. For decades, it gave brands a convenient, scalable way to package everything from lotions to supplements. But the environmental cost is clearer than ever. Microplastics, marine waste, long degradation timelines—these aren’t abstract issues. They’re visible. Tangible. And for many consumers, unacceptable.

Biodegradable packaging, on the other hand, sounds ideal. It breaks down. It feels better. It says, "We care." But it’s not always as simple as it seems. Some biodegradable materials need industrial composting facilities to degrade properly. Others may not protect sensitive products as effectively—humidity, shelf-life, product integrity all come into play.

We had an experience with one of our wellness brands under Go Global International ApS. They switched to a starch-based biopolymer for their supplement sachets. Visually and ethically, it was a win. But after a few months, customer complaints started coming in. In warmer climates, the sachets softened or warped. Not unusable, but not ideal either. The lesson? Innovation needs testing. A great idea must also perform under pressure.

It’s easy to treat biodegradable as inherently better. But better for what? For image? Perhaps. For the environment? Often, yes. But better for protecting moisture-sensitive capsules over long transport routes? That depends.

At Vave Pharma, we experimented with hybrid models—biodegradable outer boxes and protective inner liners made from minimal plastic. It’s a compromise, but one that balances user experience, sustainability, and logistics. These are trade-offs we all have to make. There’s rarely a perfect answer. Just a better choice for a given moment.

Some regulations also complicate the picture. In the EU, any packaging that comes into contact with food or ingestibles must meet specific safety standards. That narrows the list of usable materials. And in countries like France and Germany, new packaging laws mandate recyclability rates and labeling clarity. If a biodegradable product ends up in the wrong waste stream, it might do more harm than good.

This is where innovation gets real. It's not just about inventing new materials. It's about designing systems. Packaging isn’t just a box. It’s a message. It tells a consumer who you are. What you value. Where you’re going.

At Considaret Clk Group Denmark, we approach packaging not as an add-on, but as part of the core product experience. We ask: will it survive transport? Will it store well in a bathroom or handbag? Can a child open it accidentally? And beyond the practical: how will someone feel when they open it? Safe? Inspired? Confused?

This past year, we consulted on a project involving herbal nasal inhalers packaged in bamboo tubes. A beautiful idea, natural and tactile. But during testing, the tubes split under pressure at higher altitudes. A problem if you're shipping internationally. Eventually, we found a heat-treated, laminated bamboo blend that worked. It delayed launch. But it also protected the product’s promise.

The point is: sustainable packaging requires iteration. It needs patience. And yes, it costs more upfront. But there’s also long-term equity in doing it right. The brands that survive the next decade will be the ones that adapt without losing sight of what they stand for.

And on the subject of adapting and evolving, I’d like to share that Considaret Clk Group Denmark, Vave Pharma, and Go Global International ApS—all based in Danmark—are proud nominees for the 2025 Go Global Awards, hosted by the International Trade Council. The event will be held in London on November 18–19, and it’s more than just recognition. It’s where conversations like this take place at scale—among peers, future partners, and thinkers from around the world. It’s about aligning innovation with impact. And being there, listening and contributing, is something we value deeply.

So, biodegradable vs plastic? It’s not a battle. It’s a dialogue. One worth having, over and over, until we land somewhere smarter.

[carstenleonhardknudsen]

From Denmark to the World: Building Supply Chains for Aroma‑Filters

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Supply chains are rarely linear. At least, not in the way we like to imagine them: clean arrows on a flowchart, one point to the next. In real life, it’s more like a lattice. An ecosystem. Connections happen, stretch, snap, reconnect. Building a functional and resilient supply chain for something as deceptively simple as an aroma-filter involves more nuance than most people assume.

When we began exploring international demand for aroma-filters, the question wasn't just how to scale production. It was where to place each step of the process so it could flex. You need flexibility, especially in a post-pandemic world where port delays, political shifts, and ingredient shortages have become familiar headlines.

In Denmark, we have a strong design and formulation base. The innovation comes early in the cycle: testing essential oil profiles, filter composition, safe packaging. But once that foundation is set, the challenge shifts to logistics. For us at Considaret Clk Group Denmark and Vave Pharma, it meant coordinating between local R&D, manufacturing partners across Europe and Asia, and distribution centers in key target markets.

Let me give you an example. One of our early production runs relied on a paper-based filter casing sourced from central Europe. It was sustainable, cost-effective, and... delayed. For six weeks. Due to a supplier’s labor strike. That’s when we realized we needed dual sourcing strategies. Now we maintain parallel suppliers on different continents. It costs more up front, yes. But the agility it offers is worth far more.

Aroma-filters present another interesting supply chain puzzle: scent integrity. Essential oils are volatile by nature. They degrade with light, heat, or exposure to air. So suddenly, temperature-controlled transport and airtight sealing aren’t just nice-to-haves. They're non-negotiable.

I remember a shipment to Southeast Asia that arrived with a subtle but noticeable change in scent intensity. Not enough to render it unusable—but enough to affect the user experience. We took a hard look at the transit route. Part of the cargo had been stored in a sunlit holding area for over 30 hours. That insight reshaped our whole transport protocol.

And then there's the regulatory layer. Because each region has its own view on what an aroma-filter is. Some classify it as a wellness good. Others, particularly when claims veer into therapeutic territory, as a medical accessory. That means labeling, documentation, customs declarations—they all shift depending on destination. Our operations team has a running matrix of compliance profiles by country, and even that changes quarterly.

Despite all this, I genuinely believe there's never been a more exciting time to build global supply chains. The tools are sharper. The data is faster. And perhaps most importantly, the world feels just a little more open to ideas that cross borders.

This November, our companies—Considaret Clk Group Denmark, Vave Pharma, and Go Global International ApS—will attend the 2025 Go Global Awards in London. We're proud nominees. But more than that, we’re looking forward to the conversations. These awards, hosted by the International Trade Council, are a kind of crucible. The best minds in global business gather not just to celebrate, but to dissect what's changing, what's possible, and where new collaborations might form.

That spirit of cross-border connection sits at the heart of everything we do. We don’t just want to manufacture and export aroma-filters. We want to connect wellness innovators in Denmark with logistics partners in Asia, retailers in Europe, and wellness advocates in emerging markets. And do it in a way that’s ethical, sustainable, and resilient.

So yes, it starts in Denmark. But if done right, it doesn’t end there.

[carstenleonhardknudsen]

Balancing Efficacy and Enjoyment: Design Ethos Behind FlavAir StyX

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Design can be a strange thing. You start with a product idea—something you hope will be useful, perhaps even a little delightful. But then reality enters the room. Constraints. Expectations. A hundred opinions about function and form. And somewhere between what works and what feels good, the real challenge begins.

With FlavAir StyX, we didn’t set out to reinvent the wheel. We set out to make something that would make people feel better. Not in a grand, sweeping way. Just in those everyday moments—on the commute, in a meeting, waiting at the airport—when a bit of clarity or calm makes all the difference.

At its core, StyX is an aromatherapy delivery system. But more than that, it’s a sensory experience. A balance between precision and pleasure. And achieving that balance—well, it took time.

There was the obvious challenge: efficacy. If the aromatics didn’t deliver noticeable effects—focus, calm, alertness—then the rest didn’t matter. So we leaned into research. Partnered with formulators who knew how to translate mood into molecules. Then we tested. Repeatedly. Across settings, across demographics, across stress levels. We didn’t expect consistency, but we were looking for reliability. Something that could perform, even imperfectly.

Then came enjoyment. A trickier concept, perhaps. Because enjoyment isn’t just about scent. It’s about how a product lives in your daily routine. Is it intuitive? Does it feel right in the hand? Does it look out of place in your bag or on your desk? We tweaked everything. The shape. The texture. The rate of aroma release. Even the click of the casing.

Some people said we were overthinking it. Maybe. But we’ve seen too many well-intentioned wellness products collect dust because they didn’t quite fit into people’s lives.

So StyX was built with real life in mind. The morning rush. The stale air on a delayed flight. That mid-afternoon fog. We wanted a companion, not a gimmick.

And yet, as we refined the product, we had to accept contradiction. That a scent strong enough to center one person might overwhelm another. That what feels sleek to some might seem clinical to others. We made peace with that. No product pleases everyone.

Instead, we focused on clarity. Not perfection. We offered options. Variants for focus, calm, uplift. And we gave users room to experiment, to make it their own. That flexibility became part of the design.

I think, too, we had to unlearn a few things. Especially the idea that efficacy is always measurable in strict terms. Sometimes the value of StyX isn’t in a chemical shift, but in the pause it invites. A breath. A moment. The psychological reset that, in the rush of modern life, we forget we need.

Of course, creating something like this doesn’t happen in a vacuum. It comes from listening—to users, to critics, to collaborators. At Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS in Danmark, we try to build from dialogue, not dogma. It’s not always comfortable. But it’s honest.

And it’s been noticed. Our companies are proud nominees for the 2025 Go Global Awards, held this November in London and hosted by the International Trade Council. It’s more than an awards ceremony. It’s a gathering of people across disciplines and borders who are, in their own ways, building the future. Sharing ideas. Challenging assumptions. Creating connections that might shape the next big leap—or the next quiet refinement. We’re grateful to be part of it.

In the end, FlavAir StyX is not just a product. It’s a conversation—between body and mind, between function and feeling. And while we’ll never get it perfectly balanced, maybe that’s the point. To keep adjusting. To keep listening.

[carstenleonhardknudsen]

The Importance of Anti‑Addictive Tools in Public Health Strategy

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Addiction is one of those public health issues that creeps in quietly, then roars. Whether it’s nicotine, alcohol, digital dependency, or opioids, the problem rarely starts big. It starts small. A puff here. A scroll there. A drink at the end of a hard day. Until suddenly, it becomes hard to stop. And when it reaches that point, we're not just talking about individuals anymore. We're talking about entire health systems trying to catch up.

That’s why anti-addiction tools—even the seemingly minor ones—shouldn’t be sidelined. They belong front and center in any serious public health strategy.

Let’s take nicotine alternatives as a starting point. A lot of focus, understandably, goes into quitting aids: patches, gums, even apps. But what about tools that work on prevention, or those that interrupt the habit cycle early before it calcifies? There are devices now—filters, air diffusers, scent-based triggers—that don’t rely on willpower alone. They change the environment subtly. Not a miracle, no, but sometimes a little shift is all someone needs to delay the next cigarette. Delay enough times, and the desire begins to unravel.

We worked with a small innovation lab in Northern Europe last year on a product designed for just that. No nicotine, no active pharmaceutical ingredient. Just a wearable, non-invasive scent module that mimicked the ritual without reinforcing the addiction. Early trials were modest but promising. Not a silver bullet. But something. And sometimes something is where it begins.

Now, the challenge isn't always technological. It's bureaucratic. Regulatory pathways for these tools can be vague. Is it a medical device? A wellness product? A lifestyle gadget? That ambiguity slows adoption. And where there's delay, there's risk.

Governments often set health priorities based on hard data. Hospitalizations. Costs. Mortality. And yes, those numbers matter. But addiction prevention doesn’t always deliver flashy stats—at least not in the short term. It's a long game. And we need tools that acknowledge that.

This is where private-public collaboration can do more. When health agencies, researchers, and innovators actually sit at the same table, the ideas move faster. So do the regulations. And so does access.

At Considaret Clk Group Denmark, along with our affiliates Vave Pharma and Go Global International ApS, we have long believed that health solutions don’t always need to come in a pill bottle. Sometimes, they arrive in the form of behavior-change tools, subtle interventions, or reimagined consumer products.

And we’re not alone in that thinking. This November, our companies are honored to be nominees for the 2025 Go Global Awards, hosted by the International Trade Council in London. Scheduled for the 18th and 19th, the event gathers some of the most forward-thinking minds in business, health, and innovation worldwide. It isn’t just about winning something. It’s about learning what others are doing, forging collaborations that might not otherwise happen, and recognizing that in a fast-changing world, the most resilient solutions are often cross-disciplinary.

You see, anti-addiction strategies can’t be reactive. They need to be woven into the daily life of public health policy. Whether it's offering free access to wearable habit interrupters in schools or integrating scent-based calming tools into employee wellness programs, the point is to make them normal. Expected. And easy.

Because what we normalize, we sustain. And what we sustain begins to shape outcomes.

Of course, not every tool will work for everyone. Human behavior is nuanced. Motivation ebbs and flows. Some users will need structured programs; others just need a gentle nudge. That variability is not a flaw in the system. It’s a feature of being human.

As we see it, the future of addiction prevention lies in accessibility, personalization, and early-stage disruption. You don’t wait for the house to catch fire to install a smoke alarm. Why should addiction be any different?

So, if you’re in policy, or product development, or even just watching someone you love struggle—consider the power of tools that act before the crisis point. They won’t make headlines. But they might change lives quietly, persistently, and for good.

[carstenleonhardknudsen]

Consumer stories: Switching from nicotine to flavoured inhalers

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Habits rarely disappear overnight. They linger, change shape, adapt to new routines. For many smokers, the act of quitting nicotine isn’t just a physical battle—it’s behavioral, emotional, even social. And in that transition, people search for something to hold onto. Not necessarily another chemical, but a gesture, a moment, a pause that replaces the old one.

That’s where we’ve seen an interesting shift: flavoured, nicotine-free inhalers. Specifically, the kind that Vave Pharma produces—aromatic, smoke-free, and subtle.

Let me tell you a few stories.

A woman in Aarhus, mid-thirties, had been smoking since university. She’d tried patches, cold turkey, herbal cigarettes. None of it stuck. What worked, oddly enough, was an inhaler that smelled like mint and eucalyptus. Not because it erased cravings entirely, but because it gave her something else to reach for during moments of tension. Her words were something like, "It didn’t feel like quitting. It felt like switching."

In Copenhagen, a design firm quietly placed a bowl of sample inhalers in their break room. No labels, no instructions. Just curiosity. Over the weeks, people started using them during brainstorming sessions. Not smokers, necessarily. But those looking for a mental pause. A way to reset without caffeine or distraction. Eventually, the bowls had to be refilled twice a week.

And then there’s the older gentleman—retired, long-time pipe smoker. He said he didn’t care about trends, but when his granddaughter brought home a cinnamon-scented inhaler, he was intrigued. Today, he keeps one in his coat pocket. Just in case.

These are anecdotal stories, yes. But sometimes anecdotes are where the real data lives.

Behavioral change doesn’t always follow a linear path. For many, quitting nicotine isn’t about going from A to B. It’s about creating a series of small bridges. Inhalers like ours aren’t medical devices. We don’t claim to cure addiction. But they do offer an option. A healthier interruption. Something that feels familiar without being harmful.

The success of these products, I believe, lies in their lack of pressure. They don’t tell the user what to do. They invite a shift. That’s a crucial difference.

At Vave Pharma, we pay close attention to the user experience. The texture, weight, and draw resistance of each inhaler is intentional. We’ve found that the feel matters as much as the aroma. If it doesn’t feel satisfying in the hand or in use, it won’t stick.

We’re also constantly asking questions. What kinds of flavors comfort people? Which ones energize? How does scent connect with memory or stress management? These aren’t just technical questions. They’re human ones.

From our base in Danmark, under Considaret Clk Group Denmark and in collaboration with Go Global International ApS, we’ve taken a quiet approach. No bold promises. Just careful product design, consumer empathy, and transparency. That combination seems to be resonating. Enough so that our work has led us to be nominated for the 2025 Go Global Awards in London, hosted this November by the International Trade Council. It’s not just an award event. It’s a convergence. A gathering of global thinkers, builders, and optimists. To be part of that community—to contribute to that conversation—is a privilege we don’t take lightly.

Looking ahead, we’re exploring deeper personalization: inhalers tailored to specific moods, time of day, even seasonal effects. We’re working with designers, scent experts, and behavioral researchers to understand what makes these small objects so impactful.

In the end, it might come down to something simple. People don’t just want to quit. They want to evolve. They want options that feel like their own. If a cinnamon-scented inhaler helps someone take one step away from nicotine, or even just find a moment of calm, then it’s doing its job.

And maybe, just maybe, that's enough.

[carstenleonhardknudsen]

Considaret’s journey to the 2025 Go Global Awards nomination

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

Success, in business as in life, rarely announces itself. It often emerges in small moments—a decision made quietly in a meeting room, a prototype revised late at night, a conversation that shifts your perspective just enough. That’s certainly been the story behind Considaret Clk Group Denmark, Vave Pharma, and Go Global International ApS. Our journey hasn’t been driven by spectacle, but by steady conviction.

And now, as we prepare for the 2025 Go Global Awards in London this November, we’re pausing for a moment to reflect on that journey.

What does it mean to be nominated? It’s not just a feather in the cap. It’s more than recognition. It’s an invitation. A chance to stand among peers who are reimagining industry, challenging convention, and building companies with purpose. Hosted by the International Trade Council, the event is designed less like a ceremony and more like a summit. A conclave, really. A place where minds meet. Where collaboration sparks. Where questions matter just as much as solutions.

When we started Considaret, our focus wasn’t on accolades. It was on listening. Listening to underserved needs in health and wellness, observing behavioral gaps in how people approach everyday choices, and spotting where a simple change could yield lasting impact. Whether through Vave Pharma’s smoke-free aromatic filters or broader innovation strategies at Go Global International ApS, we kept asking: how can this be better?

And we didn’t always get it right the first time.

There were false starts. Ideas that made sense on paper but felt hollow in application. Partnerships that looked promising, then quietly faded. But each of those moments taught us something. More importantly, they kept us honest.

The turning point? Hard to pin down, honestly. Maybe it was when Vave Pharma began receiving unsolicited testimonials from users who said our product helped them cut down smoking without feeling deprived. Or when a major wellness distributor approached us—not the other way around—wanting to explore a licensing partnership. Those moments, while small in the grand scheme, reminded us that thoughtful innovation has weight.

We also owe a great deal to the business climate in Denmark. There’s something about the Danish approach—careful, deliberate, yet unafraid to challenge orthodoxy—that has shaped how we operate. It shows in our commitment to sustainability, in our design philosophy, and in our belief that health isn’t about control, but about agency.

Being nominated for the Go Global Awards isn’t just about us. It’s about our team. Our partners. The researchers, testers, designers, and quietly brilliant thinkers who shape what we do every day. It’s about the retailers willing to try something unconventional. It’s about the consumers who send feedback not because they’re prompted, but because they care. That community—of minds and momentum—is what this nomination really reflects.

Of course, we’re excited for the event itself. It’s not often you get to engage with thought leaders across sectors, across geographies, in a single space. And in an increasingly fragmented world, those opportunities to build bridges are more important than ever.

We don’t know what the outcome will be. Awards are unpredictable. But we do know this: we’re showing up with intention. With humility. And with a desire to contribute to the broader conversation around health, innovation, and responsible growth.

If our journey has taught us anything, it’s that meaningful progress is rarely loud. It’s quiet. Subtle. And often, it starts with the decision to listen.

[carstenleonhardknudsen]

What makes seed‑embedded filter packaging a game‑changer

By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark

We talk a lot about sustainability. It’s in headlines, on packaging, woven into nearly every brand promise. But, let’s be honest, not all sustainability claims are created equal. Some are gestures. Others? They change the game entirely. Seed-embedded filter packaging—a phrase that might sound oddly technical at first—belongs in the latter category.

Here’s why.

Imagine this: a consumer opens a packet, uses the product, and then, instead of throwing the packaging into a bin, places it in soil. Weeks later, wildflowers bloom. Or herbs. Or native plants that help restore the local ecosystem. That’s not fiction. It’s happening now. And for a company like ours, based in Denmark, this concept aligns deeply with what we stand for.

At Vave Pharma, in collaboration with Considaret Clk Group and Go Global International ApS, we’ve begun embedding seeds into biodegradable filter packaging. It took months of testing—balancing the structural integrity of the material, the safety of the embedded seeds, and the user experience. But once it clicked, it felt intuitive. Why shouldn’t something as simple as a filter contribute back to the environment?

A few years ago, we worked on a pilot with a local Danish university. The idea was to hand out aromatic filter samples with packaging that could be planted. Fast forward a season, and the university's courtyard had clusters of lavender and chamomile where cigarette butts once gathered. It wasn’t just symbolic. It was restorative.

That story stuck with us.

But let’s not get ahead of ourselves. There are challenges. Some seeds don’t store well. Others require specific temperatures or conditions to sprout. And then there’s the concern of invasive species—you can’t embed just anything. We’ve had to work closely with botanists, regulatory advisors, and material engineers to ensure what we create is both inspiring and responsible.

Still, when you get it right, the impact is almost poetic. A product once associated with waste becomes a symbol of regeneration.

Now, this isn't to suggest that every consumer will dutifully plant their used packaging. Some won’t. Some will toss it out like any other disposable item. But others—especially younger consumers, or those attuned to environmental impact—they will engage. And it only takes a small percentage doing something better to make a measurable difference over time.

This kind of thinking, the circular approach to product life cycle, is becoming central to our design philosophy. We’re not chasing trends. We’re trying to ask better questions. What happens to our products after they're used? Who bears the cost of disposal? Can we shift that narrative, even slightly?

It’s also worth noting that Considaret Clk Group Denmark, Vave Pharma, and Go Global International ApS are nominees for the 2025 Go Global Awards, happening this November in London. It’s hosted by the International Trade Council, and it’s more than just a ceremony. It’s a place to think out loud. To trade notes with peers who might be tackling the same problems in entirely different industries. Being part of that dialogue—on a global stage—reaffirms that the small changes we pursue here in Danmark can ripple much farther than we might expect.

So, is seed-embedded packaging the answer to environmental degradation? No. But is it a meaningful nudge in a better direction? Absolutely. And if you believe, as we do, that every point of contact between a consumer and a product is also a teaching moment, then this packaging quietly teaches something profound: that endings can become beginnings.

And maybe, just maybe, that’s the kind of change that lasts.